Trends in management of cardiovascular risk factors in young adults who go on to develop coronary artery disease

Back

ESC Professional Premium Access

Trends in management of cardiovascular risk factors in young adults who go on to develop coronary artery disease

Session: Lipids - Drug therapy 2

Topic: Drug therapy

Speaker: Doctor D. Vikulova (Vancouver, CA)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Diana Vikulova

University of British Columbia, Vancouver (Canada)

0 follower

6 more presentations in this session

Effect on cholesterol remnants and residual lipid risk with PCSK9 inhibitors: the LIPID-REAL Registry

Speaker: Doctor A. Cordero (Elche, ES)

Access

Abstract

Slides

Simulation study on LDL cholesterol target attainment, ASCVD events, and treatment cost of bempedoic acid in a representative German cohort of high- and very-high-CV risk patients

Speaker: Doctor J. Katzmann (Leipzig, DE)

Access

Abstract

Slides

Effect of SLCO1B1 genotypes on statin intolerance and response to statins

Speaker: Mrs L. Davis (Harefield, GB) Doctor T. Khan (Harefield, GB)

Access

Abstract

Slides

Persistence to long-term PCSK9 inhibitors treatment and its effectiveness in familial hypercholesterolemia: data from the SAFEHEART study

Speaker: Doctor R. Alonso (SANTIAGO, CL)

Access

Abstract

Slides

LDL-C goal achievement and lipid-lowering therapy in patients by atherosclerotic cardiovascular disease subtype: the SANTORINI study

Speaker: Professor K. Ray (London, GB)

Access

Abstract

Slides

Access the full session

Lipids - Drug therapy 2

Speakers: Doctor D. Vikulova, Doctor A. Cordero, Doctor J. Katzmann, Mrs L. Davis, Doctor T. Khan...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources